Advertisement

Loading...

Adherium Limited

ADR.AXASX
Healthcare
Medical - Devices
$0.002
$0.00(0.00%)
Australian Market opens in 17h 57m

Adherium Limited Fundamental Analysis

Adherium Limited (ADR.AX) shows weak financial fundamentals with a PE ratio of -0.46, profit margin of -11.41%, and ROE of 4.60%. The company generates $0.0B in annual revenue with weak year-over-year growth of -2.82%.

Key Strengths

Cash Position10.89%
PEG Ratio-0.01

Areas of Concern

ROE4.60%
Operating Margin-11.32%
Current Ratio0.82
We analyze ADR.AX's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -813.3/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-813.3/100

We analyze ADR.AX's fundamental strength across five key dimensions:

Efficiency Score

Weak

ADR.AX struggles to generate sufficient returns from assets.

ROA > 10%
-3.07%

Valuation Score

Excellent

ADR.AX trades at attractive valuation levels.

PE < 25
-0.46
PEG Ratio < 2
-0.01

Growth Score

Moderate

ADR.AX shows steady but slowing expansion.

Revenue Growth > 5%
-2.82%
EPS Growth > 10%
48.73%

Financial Health Score

Moderate

ADR.AX shows balanced financial health with some risks.

Debt/Equity < 1
-1.69
Current Ratio > 1
0.82

Profitability Score

Weak

ADR.AX struggles to sustain strong margins.

ROE > 15%
4.60%
Net Margin ≥ 15%
-11.41%
Positive Free Cash Flow
No

Key Financial Metrics

Is ADR.AX Expensive or Cheap?

P/E Ratio

ADR.AX trades at -0.46 times earnings. This suggests potential undervaluation.

-0.46

PEG Ratio

When adjusting for growth, ADR.AX's PEG of -0.01 indicates potential undervaluation.

-0.01

Price to Book

The market values Adherium Limited at -7.50 times its book value. This may indicate undervaluation.

-7.50

EV/EBITDA

Enterprise value stands at -0.33 times EBITDA. This is generally considered low.

-0.33

How Well Does ADR.AX Make Money?

Net Profit Margin

For every $100 in sales, Adherium Limited keeps $-11.41 as profit after all expenses.

-11.41%

Operating Margin

Core operations generate -11.32 in profit for every $100 in revenue, before interest and taxes.

-11.32%

ROE

Management delivers $4.60 in profit for every $100 of shareholder equity.

4.60%

ROA

Adherium Limited generates $-3.07 in profit for every $100 in assets, demonstrating efficient asset deployment.

-3.07%

Following the Money - Real Cash Generation

Operating Cash Flow

Adherium Limited generates limited operating cash flow of $-8.93M, signaling weaker underlying cash strength.

$-8.93M

Free Cash Flow

Adherium Limited generates weak or negative free cash flow of $-8.98M, restricting financial flexibility.

$-8.98M

FCF Per Share

Each share generates $-0.00 in free cash annually.

$-0.00

FCF Yield

ADR.AX converts -2.28% of its market value into free cash.

-2.28%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.46

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.01

vs 25 benchmark

P/B Ratio

Price to book value ratio

-7.50

vs 25 benchmark

P/S Ratio

Price to sales ratio

4.31

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-1.69

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.82

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

4.60

vs 25 benchmark

ROA

Return on assets percentage

-3.07

vs 25 benchmark

ROCE

Return on capital employed

16.51

vs 25 benchmark

How ADR.AX Stacks Against Its Sector Peers

MetricADR.AX ValueSector AveragePerformance
P/E Ratio-0.4628.31 Better (Cheaper)
ROE459.94%699.00% Weak
Net Margin-1141.40%-130884.00% (disorted) Weak
Debt/Equity-1.690.34 Strong (Low Leverage)
Current Ratio0.822775.16 Weak Liquidity
ROA-307.04%-14469.00% (disorted) Weak

ADR.AX outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Adherium Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-99.14%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

97.40%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

96.81%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ